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Abstract: 
Objective: To determine the prevalence of depression among the diabetics presented diabetic clinic and in-patient at 
Jinnah Postgraduate Medical Centre Karachi.  
Patients and Methods: Cross-sectional study was conducted in Medical Unit 3, Ward 7, Jinnah Postgraduate 
Medical Centre, over two months in 132 diabetic (type 1 and 2) patients. Information regarding Diabetes was taken 
through interview and Prime-MD Patient Health Questionnaire (PHQ-9) was used to assess for depression. 
Patients having a score of 5 and above were considered depressed 
Results: 64.5% of diabetics were found out to be depressed. Of those who were depressed, 84.4% had a bad 
diabetic control over the last 3 months, 71.7% had gastrointestinal symptoms, 66% had diabetes for more than 10 
years. 
Conclusion: Depression in known diabetics can be lethal so it’s management, either supportive or with 
medications, should be started as soon as it is diagnosed. Also the factors which show a clear correlation with 
development of depression should be minimized as early as possible. 
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INTRODUCTION:  
The depressive disorder is a syndrome that reflects a 
sad, blue mood exceeding normal sadness or grief 
characterized not only by negative thoughts, moods, 
and behaviors but also by specific changes in bodily 
functions. One in 10 people will have a depressive 
disorder in their lifetime, and in one of 10 cases, 
the depression is a fatal disease as a result of suicide. 
Some types of depression run in families. Since this 
illness is diagnosed only clinically, complete physical 
and psychological assessment is necessary. A person 
cannot will it away. Untreated, it will worsen. 
Undertreated, it will return. The liaison between 
diabetes and depression is bidirectional [1]. 
Depression when hits a diabetic person, this turns out 
to be even more detrimental than diabetes alone. 
Depression may contribute to poor diabetes-related 
outcomes, similarly diabetes and its complications 
may also contribute to poor depression outcomes in 
patients all over the world [2]. The distinct 
correlation demands timely management of each of 
these illnesses in order to reduce the associated 
morbidity and mortalityi  plus the cost of healthcare 
[3, 4]. Gender difference carries significance both for 
diabetes and depression, so does age. Unemployment 
means physical under-activity as well as a 
psychological challenge. Alike independent factors 
are certainly influential [5]. Regarding the 
complications of diabetes and metabolic syndrome, 
duration of diabetes, gastrointestinal symptoms, 
complaints of peripheral neuropathy, deranged 
glycemic control, and other micro and macro-
vascular impediments possibly lead to poorer 
depression grades. Likewise depression increases the 
likelihood of such complications in diabetics [6]. The 
rationale of our study was to learn the statistics of the 
diabetic inhabitants who suffer from depression 
concomitantly in our part of the world for the reason 
that data from here is scanty.  
 
PATIENTS & METHODS:  
A cross-sectional analytical study was conducted 
over a period of two months that is from October 
2015 to November 2015 on Pakistani, type 1 and type 
2 diabetic males and females irrespective of age 
presented to the diabetic clinic at Medical Unit 3, 
Ward 7, Jinnah Postgraduate Medical Centre, 
Karachi. The sample size was calculated to be 121 by 
Raosoft® software online.  
A form with incorporated parameters required for 
recording gender, age, employment status, self-
monitoring, compliance and duration of diabetes was 
filled up by house physicians and internal medicine 
residents. Information regarding diabetic control was 
gathered by HbA1c reports done on ELISA within 
past three months. Patients already on antidepressant 
medications were excluded. 
Prime MD Patient Health Questionnaire (PHQ-9) was 
used to assess for depression [7]. The questionnaire 
was translated to Urdu, the native language. A score 
of 5 and above labeled them as depressed (No 
Depression: score less than 4, Mild Depression: score 
between 5 and 9, Moderate Depression: score 
between 10 and 14, moderately severe Depression: 
score between 15 and 19, Severe Depression: score 
between 20 and 27). 
Statistical Analysis was performed on SPSS version 
22.0. Percentages were used for data expression. Chi-
square testing was done to see a correlation between 
categorical variables. P-values < 0.05 were meant to 
show an association. 
 
RESULTS:  
64.5% of diabetics were found out to be depressed. 
Of those who were depressed, 84.4% had a bad 
diabetic control over the last 3 months, 71.7% had 
gastrointestinal symptoms, 66% had diabetes for 
more than 10 years. The cross tabulations for the 
study population are shown in Table 1-8. 
TABLE 1: THE DISTRIBUTION FOR AGE AND GENDER 
 
  GENDER 
Total   Male Female 
AGE (yrs) < 40 5 20 25 
17.9% 21.5% 20.7% 
41 - 50 10 38 48 
35.7% 40.9% 39.7% 
51 - 65 13 35 48 
46.4% 37.6% 39.7% 
Total 28 93 121 
100.0% 100.0% 100.0% 
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TABLE 2: THE DISTRIBUTION FOR TYPE OF DIABETES AND GENDER 
  
GENDER 
Total   Male Female 
Type of diabetes 1 0 2 2 
.0% 2.2% 1.7% 
2 28 91 119 
100.0% 97.8% 98.3% 
Total 28 93 121 
100.0% 100.0% 100.0% 
 
 
TABLE 3: THE DISTRIBUTION OF GENDER AND DURATION OF DIABETES MELLITUS 
  
GENDER 
Total   MALE FEMALE 
DURATION (yrs) Newly diagnosed 6 24 30 
21.4% 25.8% 24.8% 
1-5 5 27 32 
17.9% 29.0% 26.4% 
6-10 9 26 35 
32.1% 28.0% 28.9% 
>10 8 16 24 
28.6% 17.2% 19.8% 
Total 28 93 121 
100.0% 100.0% 100.0% 
 
TABLE 4: THE DISTRIBUTION OF GENDER AND HEMOGLOBIN A1C 
  
GENDER 
Total 
  
MALE FEMALE 
HBA1C ≤ 7 7 14 21 
25.0% 15.1% 17.4% 
> 7 21 79 100 
75.0% 84.9% 82.6% 
Total 28 93 121 
100.0% 100.0% 100.0% 
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TABLE 5: THE DISTRIBUTION FOR GENDER AND INSULIN THERAPY 
  
GENDER 
Total   Male Female 
INSULIN Yes 6 22 28 
21.4% 23.7% 23.1% 
No 22 71 93 
78.6% 76.3% 76.9% 
Total 28 93 121 
100.0% 100.0% 100.0% 
 
TABLE 6: THE DISTRIBUTION OF GENDER AND ORAL HYPOGLYCEMIC DRUGS 
  
GENDER 
Total 
  
Male Female 
OHGD Yes 26 86 112 
92.9% 92.5% 92.6% 
No 2 7 9 
7.1% 7.5% 7.4% 
Total 28 93 121 
100.0% 100.0% 100.0% 
 
 
TABLE 7: THE DISTRIBUTION OF GENDER AND PHQ9 
  
GENDER 
Total   Male Female 
PHQ9 0-4 12 30 42 
42.9% 32.3% 34.7% 
5-9 9 29 38 
32.1% 31.2% 31.4% 
10-14 5 22 27 
17.9% 23.7% 22.3% 
15-19 2 11 13 
7.1% 11.8% 10.7% 
20-27 0 1 1 
.0% 1.1% .8% 
Total 28 93 121 
100.0% 100.0% 100.0% 
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TABLE 8: THE FREQUENCY OF DEPRESSION IN PATIENTS WITH DIABETES MELLITUS 
  GENDER 
Total  Depression MALE FEMALE 
 No 12 30 42 
42.9% 32.3% 34.7% 
Yes 16 63 79 
57.1% 67.7% 65.3% 
Total 28 93 121 
100.0% 100.0% 100.0% 
 
DISCUSSION:  
The former epidemiological surveys observed that 
depression was more common in patients with 
diabetes mellitus regardless of diagnosed or 
undiagnosed diabetes mellitus while the anxiety was 
more identified in individual who has diabetes 
awareness [8]. It can be state that the psychological 
burden can play major role as far as anxiety / 
depression and diabetes is concerned [9]. However, 
in previously undiagnosed diabetic population the 
depression has a high prevalence due to unhealthy 
diet, unfavorable physical activity and stressful life 
routine [10]. A former meta-analysis determined the 
association between neuropathy in type 2 diabetes 
mellitus and depression [10]. The level of depression 
could be augmented by anti-diabetic medications 
[11]. On the contrary, the insulin therapy in elderly 
population with type 2 diabetes mellitus resulted in 
improvement in symptoms of depression and did not 
affect the quality of life [12]. The diabetes mellitus 
causes structural alterations in brain: the lacunar 
infarcts, cerebral atrophy and blood flow alterations 
of both hyper and hypo- perfusion [13, 14]. The brain 
volume reduction limited to hippocampus was 
detected in diabetic population, whereas the inverse 
association among hippocampal volume and 
glycemic status was present. Similarly, depression 
has association with neurodegenerative processes 
especially at the level of the hippocampus and 
prefrontal cortex [15]. Petrak et al. advised 
depression treatment as priority basis because the 
response to medication usually observed within two 
to four weeks for antidepressants whereas the 
glycemic improvement and HbA1C control needs 
several months to be settled [16]. Moreover, Petrak et 
al. observed that patients with better mood usually 
follow diabetic treatment strategies [16] and acts as a 
model for managing depression and diabetes mellitus, 
stepped in relation to the degree of depression [16]. 
The approach would be to detect the main triggers for 
diabetes mellitus and depression & address them in 
public seminars but advance studies should be 
conducted in preventing and controlling 
inflammatory responses and stress. 
 
CONCLUSION:  
In diabetic population, the depression remains under-
diagnosed and a major aspect for diabetologist to 
create awareness for this common co-morbidity. 
Thus, the multidisciplinary strategies of the diabetic 
population could be helpful to improve the disease 
burden and its outcome and also to decrease the 
mortality. 
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